India Insulin Delivery Devices Market Overview, 2028

India is at the forefront of global healthcare innovations, and the insulin delivery device market has seen amazing growth and innovation within its diverse healthcare landscape. As the country grapples with rising diabetes prevalence, considered being among the highest in the world, demand for effective diabetes management options, such as insulin delivery devices, has increased. The insulin delivery device industry in India is seeing a wave of technical innovation. Manufacturers are incorporating smart features, connection possibilities, and pen design innovations to improve patient experience and treatment outcomes. The growing accessibility and affordability of these devices is one of the primary drivers in India's insulin delivery device market. Various alternatives, including reusable pens and disposable variations, cater to a wide range of patient needs and cost considerations. The insulin delivery device market has been considerably impacted by government attempts to reduce diabetes and enhance healthcare access. Diabetes awareness, preventive healthcare, and economical treatment choices have all aided market expansion. The insulin delivery device market in India is evolving as a result of technical breakthroughs, patient needs, and a concentrated effort to address diabetes's difficulties. Collaborations between healthcare providers, technology companies, and research institutions promise a creative, accessible, and patient-centred future. Diabetes management is influenced by India's preference for traditional medicine and integrative healthcare practices. Complementary and alternative medicines, as well as herbal cures, coexist with traditional treatments. Exploring integrative solutions in conjunction with insulin delivery devices is becoming more popular. The growing emphasis on patient empowerment is driving the development of insulin delivery devices that include self-management features. Patient empowerment is aided by user-friendly gadgets that include instructional resources and integrated support systems.

According to the research report "India Insulin Delivery Devices Market Overview, 2028," published by Bonafide Research, the India Insulin Delivery Devices market is expected to grow with more than 10% CAGR from 2023 to 2028. One of the world's largest diabetic populations is found in India. The country is dealing with a substantial diabetes burden, with millions of people diagnosed, contributing to a strong need for insulin and insulin delivery devices. Type 2 diabetes is more common in India than type 1 diabetes. Type 2 diabetes is becoming more common as a result of lifestyle factors, genetic predispositions, and urbanisation, necessitating the use of insulin delivery devices for control. Access to contemporary healthcare facilities and insulin delivery devices is frequently difficult in rural areas. Efforts are currently underway to close the gap and ensure fair access to diabetes control tools in both urban and rural areas. The government has been concentrating on its National Health Policy, which aims to improve healthcare infrastructure and access to key pharmaceuticals such as insulin and related delivery devices. The government's drive to promote domestic production has had an impact on the healthcare sector. There have been efforts to stimulate local production of medical equipment such as insulin pumps and pens in order to lessen reliance on imports and make these devices more inexpensive and accessible. The Central Drugs Standard Control Organisation (CDSCO) is in charge of ensuring the safety, efficacy, and quality of medical equipment, including insulin delivery systems. They are working to simplify approval processes in order to stimulate the entry of innovative yet safe products into the Indian market.

Based on product market is majorly divided into insulin pens, insulin pumps, insulin pen needles, insulin syringes and others insulin delivery devices (insulin transdermal patches, insulin inhalers, insulin jet injection). Among them Insulin pens product type is expected to dominate the India insulin delivery devices market with significant market share. Insulin pens are easy to use and handy, especially for self-administration. They are prefilled, portable, and provide a discrete way to take insulin, making them more accessible to diabetic people. Insulin pens are compatible with a variety of insulins, including rapid-acting, short-acting, intermediate-acting, and long-acting insulins, providing treatment versatility. Because of their effectiveness and convenience of use, insulin pens are likely to be included in the Indian government's initiatives to promote affordable healthcare and diabetes control. Based on end user market is bifurcated into home care, hospitals and clinics and others. Among them home care settings are major end user of India insulin delivery devices market. Home care enables diabetics to manage their disease simply in the comfort of their own homes. It reduces the need for regular insulin administration trips to hospitals or clinics. With diabetes becoming more prevalent in India, there is a greater need for better diabetes control options. Home care settings enable personalised treatment and regular monitoring, which is critical for diabetes management. The COVID-19 pandemic has highlighted the importance of home care settings in reducing exposure to overcrowded hospitals, making them a safer alternative for people who need frequent insulin administration.

In terms of indication market is majorly segmented into diabetes, pregnancy, cardiovascular disorders & hypertension, respiratory diseases, hearing disorders, cancer, movement disorders, wound care and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Diabetes indication segment is significantly dominating the market of India insulin delivery devices. Diabetes is a major public health concern in India, affecting a large proportion of the population. As insulin remains a critical treatment for many diabetic patients, the rising prevalence of diabetes has produced a significant need for insulin administration systems. Insulin use has increased as diabetes treatment alternatives have improved. Along with traditional insulin injections, newer and more modern technologies, such as insulin pens, pumps, and continuous glucose monitors (CGMs), are available to help with disease management. Demand for these devices in the diabetes indication sector is driven by this. Patients frequently prefer easy and user-friendly insulin administration systems that help them manage their condition. Insulin pens and pumps, for example, provide more precise dosing, flexibility, and ease of use than traditional vial and syringe approaches. Government measures to improve diabetes treatment, improve access to healthcare services, and subsidise or make critical diabetes medications and devices more affordable have all contributed to the rise of the diabetes indication category in the insulin delivery device market.

Considered in this report:
• Geography: India
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028



Aspects covered in this report:
• India Insulin Delivery Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Insulin Pens
• Insulin Pumps
• Insulin Pen Needles
• Insulin Syringes
• Others Insulin Delivery Devices(Insulin transdermal patches, Insulin inhalers, Insulin jet injection)

By End User:
• Home Care
• Hospitals & Clinics
• Others

By Indication:
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Respiratory Diseases
• Hearing Disorders
• Cancer
• Movement Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Insulin Delivery Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.